https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accrued-royalties-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability-1 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/buybacks-payments-for-hedge-financing-activities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/congressional-trades-other https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/construction-in-progress-gross https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/convertible-securities-retired https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/income-tax-examination-increase-decrease-in-liability-from-prior-year https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/insider-transactions-corporate-securities/sales https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-work-in-process-and-raw-materials https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-gain-loss-included-in-earnings https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-gain-loss-included-in-oci-loss https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-gain-loss-included-in-other-comprehensive-income https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-purchases-sales-issuances-settlements https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-sales https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-transfers-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-asset-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/level-3-liability-settlements https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/line-of-credit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/loss-on-sale-of-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/net-rentable-area https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/new-claims-filed-number https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-value-of-liabilities-assumed https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/option-indexed-to-issuers-equity-strike-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/other-receivables https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/payments-for-derivative-instrument-financing-activities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/payments-for-purchase-of-other-assets https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/payments-for-purchase-of-other-assets-1 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/production-related-impairments-or-charges https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/realized-gains-on-securities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/research-and-development-arrangement-with-federal-government-costs-incurred-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-prer14a https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/shares-issued-shares-restricted-stock-award-forfeited https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/short-term-debt https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-term-maximum https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-compensation-unrecognized-cost-recognition-period https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-exercisable-remaining-term https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-outstanding-remaining-term https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-remaining-term https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stockholders-equity-change https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/treasury-stock-value https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/utb-change https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/weighted-average-number-of-shares-issued-basic https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/weighted-average-number-of-shares-outstanding-basic-and-diluted https://stock.noler.com/us/stock/auxilium-pharmaceuticals-inc/weighted-average-number-of-shares-restricted-stock